Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Takeda
Pharma
Enhertu successor, ESMO, Gilead—Fierce Pharma Asia
Fierce provides a deep dive into the hunt for the next Enhertu in breast cancer. ESMO 2026 data featured Chinese assets backed by Big Pharma.
Angus Liu
Oct 30, 2026 8:45am
Takeda, Daiichi, Samsung Bio and more—Fierce Pharma Asia
Sep 11, 2026 9:15am
Roche, GSK, Novartis, MFN, Akeso and more—Fierce Pharma Asia
Sep 4, 2026 8:52am
FDA approves label expansion for PharmaEssentia's Besremi
Aug 31, 2026 8:25am
Takeda wins FDA nod for first-in-class blood cancer drug Mimrylo
Aug 28, 2026 10:04pm
Of biopharma's top 25 companies, 9 had double-digit sales bumps
Aug 12, 2026 11:47am
